OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
117
Results
Show all
Save search
Copy query
Show results for
Unknown
(117)
Publication Date
Release Date
2021
(21)
2022
(16)
2023
(15)
2015
(11)
2018
(10)
2024
(8)
2025
(7)
2020
(6)
2016
(6)
2019
(4)
2013
(4)
2017
(3)
2014
(2)
2011
(2)
2026
(1)
2009
(1)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Grocery Purchase Changes Were Associated With A North Carolina COVID-19 Food Assistance Incentive Program.
Not available
S-EPMC10191414
|
biostudies-literature
Cite
Large-scale transcriptome-wide association study identifies new prostate cancer risk regions.
Not available
S-EPMC6172280
|
biostudies-literature
Cite
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
Not available
S-EPMC7413371
|
biostudies-literature
Cite
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520
|
biostudies-literature
Cite
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
Not available
S-EPMC7489418
|
biostudies-literature
Cite
Accelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727
|
biostudies-literature
Cite
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Not available
S-EPMC8274471
|
biostudies-literature
Cite
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Not available
S-EPMC6137048
|
biostudies-literature
Cite
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Not available
S-EPMC9857594
|
biostudies-literature
Cite
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets